This content is machine translated Pulmonary arterial hypertension (PAH) Results of the Phase III STELLAR study show therapeutic progress In pulmonary arterial hypertension, sotatercept improved primary and secondary endpoints, and thus numerous disease parameters, in a phase 3 study, in addition to standard combination therapy. The molecule targets a…
